Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 15,034,000 | 14,451,000 | 17,557,000 | 16,654,000 | 14,653,000 |
| Cost of Goods | 4,092,000 | 3,548,000 | 5,272,000 | 4,172,000 | 3,778,000 |
| Gross Profit | 10,942,000 | 10,903,000 | 12,285,000 | 12,482,000 | 10,875,000 |
| Operating Expenses | 7,878,000 | 6,871,000 | 9,413,000 | 8,631,000 | 7,092,000 |
| Operating Income | 3,064,000 | 4,032,000 | 2,872,000 | 3,851,000 | 3,783,000 |
| Other Income | -3,717,000 | -862,000 | -4,515,000 | -517,000 | -739,000 |
| Pre-tax Income | -653,000 | 3,170,000 | -1,643,000 | 3,334,000 | 3,044,000 |
| Income Tax | -407,000 | 461,000 | -2,000 | -216,000 | 141,000 |
| Net Income Continuous | -246,000 | 2,709,000 | -1,639,000 | 3,550,000 | 2,903,000 |
| Net Income Discontinuous | 8,000 | -13,000 | N/A | 0 | 25,000 |
| Minority Interests | 10,000 | 8,000 | 8,000 | 9,000 | 18,000 |
| Net Income | $-247,000 | $2,688,000 | $-1,647,000 | $3,541,000 | $2,910,000 |
| EPS Basic Total Ops | -0.04 | 0.47 | -0.28 | 0.62 | 0.51 |
| EPS Basic Continuous Ops | -0.04 | 0.48 | -0.28 | 0.62 | 0.51 |
| EPS Diluted Total Ops | -0.04 | 0.47 | -0.29 | 0.62 | 0.51 |
| EPS Diluted Continuous Ops | -0.04 | 0.47 | -0.29 | 0.62 | 0.51 |
| EPS Diluted Before Non-Recurring Items | 0.77 | 0.75 | 0.66 | 0.87 | 0.78 |
| EBITDA(a) | $4,686,000 | $5,645,000 | $4,559,000 | $5,513,000 | $5,408,000 |